Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers Z > Headlines for Ziopharm Oncology, Inc. > News item |
Ziopharm files $100 million shelf covering preferreds, debt, stock
By Devika Patel
Knoxville, Tenn., April 30 - Ziopharm Oncology, Inc. filed a $100 million shelf registration in an S-3 filing with the Securities and Exchange Commission.
The registration covers common stock, preferred stock, debt securities and warrants.
The securities may be structured as convertibles.
Proceeds will be used for working capital and general corporate purposes.
New York-based Ziopharm develops treatments for cancer.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.